Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer

Robert C. Flanigan; Sydney E. Salmon; Brent A. Blumenstein; Scott I. Bearman; Vivek Roy; Patrick C. McGrath; J. R. Caton; Nikhil C. Munshi; E. David Crawford

doi:10.1056/nejmoa003013

Abstract

Nephrectomy followed by interferon therapy results in longer survival among patients with metastatic renal-cell cancer than does interferon therapy alone.

Keywords

MedicineNephrectomyRenal cell carcinomaInterferon alfaAlpha interferonInterferonInternal medicineCancerChemotherapyGastroenterologyKidneySurgeryUrologyOncologyImmunology

Affiliated Institutions

Related Publications

Cytoreductive Nephrectomy in Patients With Metastatic Renal Cancer: A Combined Analysis

Robert C. Flanigan , G. Mickisch , Richard Sylvester +3 more

Cytoreductive nephrectomy appears to improve significantly overall survival in patients with metastatic renal cancer treated with interferon immunotherapy independent of patient...

2004 The Journal of Urology 869 citations

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

GHJ Mickisch , A. Garin , Hendrik Van Poppel +2 more

2001 The Lancet 1403 citations

Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists.

Three cycles of neoadjuvant chemotherapy before cystectomy or radiotherapy did not give the 10% improvement in 3-year survival that was judged to be necessary for introduction i...

1999 PubMed 162 citations

Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma

Thomas Powles , Se Hoon Park , Éric Voog +24 more

Maintenance avelumab plus best supportive care significantly prolonged overall survival, as compared with best supportive care alone, among patients with urothelial cancer who h...

2020 New England Journal of Medicine 1374 citations

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Brian I. Rini , Elizabeth R. Plimack , V.P. Stus +24 more

Among patients with previously untreated advanced renal-cell carcinoma, treatment with pembrolizumab plus axitinib resulted in significantly longer overall survival and progress...

2019 New England Journal of Medicine 3200 citations

Publication Info

Year: 2001
Type: article
Volume: 345
Issue: 23
Pages: 1655-1659
Citations: 1719
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1719

OpenAlex

Cite This

APA Style

                            
                                
                                    Robert C. Flanigan, 
                                
                                    Sydney E. Salmon, 
                                
                                    Brent A. Blumenstein
                                
                                et al.
                            
                            (2001). 
                            Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer. 
                            New England Journal of Medicine
                            , 345
                            (23)
                            , 1655-1659.
                            https://doi.org/10.1056/nejmoa003013
                        

Identifiers

DOI: 10.1056/nejmoa003013